InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-01 · accession 0001127602-22-013019 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-03 2022-05-01 MRK Klobuchar Michael A EVP - Chief Strategy Off F - Tax $88.69 -427 14.5K -3% -$37.9K
D 2022-05-03 2022-05-01 MRK Klobuchar Michael A EVP - Chief Strategy Off M - OptEx $88.69 +866 14.9K +6% +$76.8K
D 2022-05-03 2022-05-01 MRK Klobuchar Michael A EVP - Chief Strategy Off M - OptEx $0.00 -866 866 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-01 F D 427 $88.69 14,497.93 D — — (F1) Holdings include shares acquired in dividend reinvestment transactions.
2 Common Common Stock 2022-05-01 M A 866 $88.69 14,924.93 D — —
3 Derivative Restricted Stock Unit 2022-05-01 M D 866 $0.00 866 D — · 2021-05-01 to 2023-05-01 866 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F4) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.